Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America
; ;  [1]
  1. Lawrence Berkeley National Lab., CA (United States); and others

The central role of cyclin-dependent kinases (CDKs) in cell cycle regulation makes them a promising target for studying inhibitory molecules that can modify the degree of cell proliferation. The discovery of specific inhibitors of CDKs such as polyhydroxylated flavones has opened the way to investigation and design of antimitotic compounds. A novel flavone, (-)-cis-5,7-dihydroxyphenyl-8-[4-(3-hydroxy-1-methyl)piperidinyl]-4H-1-benzopyran-4-one hydrochloride hemihydrate (L868276), is a potent inhibitor of CDKs. A chlorinated form, flavopiridol, is currently in phase I clinical trials as a drug against breast tumors. We determined the crystal structure of a complex between CDK2 and L868276 at 2.33-{Angstrom} resolution and refined to an R{sub factor} of 20.3%. The aromatic portion of the inhibitor binds to the adenine-binding pocket of CDK2, and the position of the phenyl group of the inhibitor enables the inhibitor to make contacts with the enzyme not observed in the ATP complex structure. The analysis of the position of this phenyl ring not only explains the great differences of kinase inhibition among the flavonoid inhibitors but also explains the specificity of L868276 to inhibit CDK2 and CDC2. 36 refs., 4 figs., 2 tabs.

Sponsoring Organization:
USDOE
DOE Contract Number:
AC03-76SF00098
OSTI ID:
258594
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America, Journal Name: Proceedings of the National Academy of Sciences of the United States of America Journal Issue: 7 Vol. 93; ISSN PNASA6; ISSN 0027-8424
Country of Publication:
United States
Language:
English

Similar Records

Crystal structure of a human cyclin-dependent kinase 6 complexwith a flavonol inhibitor, Fisetin
Journal Article · Sun Jan 09 23:00:00 EST 2005 · Journal of Medicinal Chemistry · OSTI ID:860892

Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding
Journal Article · Sat Jun 03 00:00:00 EDT 2023 · Nature Communications · OSTI ID:2423378

Structural basis of divergent cyclin-dependent kinase activation by Spy1/RINGO proteins
Journal Article · Fri Jun 30 00:00:00 EDT 2017 · EMBO Journal · OSTI ID:1368205